This segment focuses on the research, development, manufacturing, and commercialization of traditional Chinese medicine products. R&D activities include the study of herbal formulations, extraction techniques, and the development of new dosage forms like granules and tablets. Technologies employed involve advanced extraction and purification processes to ensure product quality and efficacy. Therapeutic areas covered include digestive system, respiratory system, cardiovascular health, and other areas addressed by TCM. The patient impact is significant, as these products offer alternative and complementary treatments. Market positioning is strong in China, with opportunities for global expansion. Future growth will be driven by increasing demand for natural and holistic healthcare solutions. Regulatory aspects involve compliance with Chinese Pharmacopoeia standards and international regulations for export. Partnerships with research institutions and TCM practitioners are crucial for innovation and market access.

This segment encompasses the development, manufacturing, and distribution of modern pharmaceutical products. R&D efforts focus on the formulation and production of various dosage forms, including tablets, capsules, and injections, for a wide range of therapeutic areas. Technologies used include advanced manufacturing processes, quality control systems, and packaging technologies. Therapeutic areas include systemic anti-infective drugs, analgesics, and drugs for the digestive, respiratory, and cardiovascular systems. The segment aims to improve patient outcomes through effective and accessible medications. Market positioning is competitive, requiring continuous innovation and adherence to stringent regulatory standards. Future opportunities lie in expanding the product portfolio and entering new markets. Regulatory compliance with both Chinese and international standards is critical. Strategic partnerships with global pharmaceutical companies can facilitate technology transfer and market access.